41.106 makale bulundu

[L-dopa in the treatment of parkinsonism].

Goldsztajn M, Reichowa J.

Przegl Lek · 1971-09-01

PMID: 4942580

[Pathomechanism and pharmacological treatment of Parkinson's disease].

Pakszys W.

Pol Tyg Lek · 1971-06-01

PMID: 4935461

L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.

Lewis I.

J Med Assoc State Ala · 1971-05-01

PMID: 5573008

L-dopa therapy in Parkinson's disease.

Lipman IJ.

Va Med Mon (1918) · 1971-05-01

PMID: 4931138

The shaking patient and advances in the therapy of Parkinsonism.

McMasters RE.

Mod Treat · 1971-05-01

PMID: 4940512

[Therapy and problems of parkinsonism].

Albert E.

Nervenarzt · 1971-05-01

PMID: 4942900

Pathophysiology of Parkinson's disease.

McLeod JG.

Aust N Z J Med · 1971-05-01

DOI: 10.1111/j.1445-5994.1971.tb02561.xPMID: 4949270

Parkinson's syndrome: aetiological factors and certain clinical features.

Sutherland JM.

Aust N Z J Med · 1971-05-01

DOI: 10.1111/j.1445-5994.1971.tb02563.xPMID: 4949272

The past, present and future of surgical procedures in Parkinson's disease.

Bleasel K.

Aust N Z J Med · 1971-05-01

DOI: 10.1111/j.1445-5994.1971.tb02565.xPMID: 4949273

A summary of overseas experience with L-dopa in Parkinson's disease.

Fisher AG.

Aust N Z J Med · 1971-05-01

DOI: 10.1111/j.1445-5994.1971.tb02566.xPMID: 4949274

Wolff-Parkinson-White sendromu ile ilişkili olarak organik kalp hastalığının ortaya çıkması - 29 vakanın analizi.

Occurrence of organic heart disease in association with the Wolff-Parkinson-White syndrome--analysis of 29 cases.

Nasser WK, Mishkin ME, Tavel ME, Genovese PD.

J Indiana State Med Assoc · 1971-02-01

PMID: 5101402

Parkinson hastalığının metabolik modifikasyonu ve kronik manganez zehirlenmesi.

Metabolic modification of Parkinson's disease and of chronic manganese poisoning.

Cotzias GC, Papavasiliou PS, Ginos J, Steck A, Düby S.

Annu Rev Med · 1971-01-01

DOI: 10.1146/annurev.me.22.020171.001513PMID: 4944422